GLTO
Galecto, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website galecto.com
- Employees(FY) 45
- ISIN US36322Q1076
Performance
-11.28%
1W
-9.63%
1M
-11.42%
3M
+4.39%
6M
-13.74%
YTD
-73.05%
1Y
Profile
Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB0139, an inhaled small molecule inhibitor of galectin-3 that is in Phase IIb clinical trial for the treatment of fibrotic lung diseases, such as idiopathic pulmonary fibrosis, a life-threatening progressive fibrotic disease of the lung; GB2064, a selective oral small molecule inhibitor of LOXL2 that is in Phase 2a clinical trial for the treatment of myelofibrosis; and GB1211, a selective oral galectin-3 inhibitor that is in Phase IIa for the treatment of cancer, as well as in Phase Ib/IIa for fibrosis. Galecto, Inc. was founded in 2011 and is headquartered in Copenhagen, Denmark.
Technical Analysis of GLTO 2024-05-10
Overview:
In analyzing the technical indicators for GLTO over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day Moving Average (MA) has been fluctuating around the 0...
Recent News & Updates
- 2024-05-02 22:54
GLTO Stock Earnings: Galecto Beats EPS for Q1 2024(Investorplace)
- 2024-05-01 04:01
- 2024-03-15 01:53
GLTO Stock Earnings: Galecto Beats EPS for Q4 2023(Investorplace)
- 2024-02-13 23:00
- 2024-01-09 03:57
What Makes Galecto, Inc. (GLTO) a New Strong Buy Stock(Yahoo Finance)
- 2023-12-21 17:52
- 2023-12-21 03:05
- 2023-10-22 20:00
- 2023-09-27 21:49
- 2023-09-26 17:08
- 2023-09-26 04:01
Galecto Announces Plans to Explore Strategic Alternatives(Yahoo Finance)
- 2023-08-30 23:00
Galecto to Present at Investor Conferences in September(Yahoo Finance)
- 2023-08-17 07:01
OrbiMed Advisors LLC Reduces Stake in Galecto Inc(Yahoo Finance)
- 2023-08-16 20:58
- 2023-08-15 19:46
Galecto (GLTO) Down 71% as Lung Disease Candidate Fails(Yahoo Finance)
- 2023-08-14 19:35
Galecto to discontinue development of lung disease treatment(Yahoo Finance)
- 2023-08-14 19:30
- 2023-07-31 04:05
- 2023-07-27 11:02
ORBIMED ADVISORS LLC Reduces Stake in Galecto Inc(Yahoo Finance)
- 2023-07-24 21:59
These 2 Strong Buy Penny Stocks Could Go Boom, Say Analysts(Yahoo Finance)
- 2023-06-19 20:58
Galecto Set to Join Russell Microcap® Index(Yahoo Finance)
- 2023-05-29 20:00
- 2023-05-22 20:30
- 2023-05-19 20:54
Companies Like Galecto (NASDAQ:GLTO) Could Be Quite Risky(Yahoo Finance)
- 2023-05-17 04:01
- 2023-04-27 20:00
- 2023-04-12 20:30
Galecto to Present Two Posters at AACR Annual Meeting 2023(Yahoo Finance)
- 2023-03-08 18:00
- 2023-03-02 03:05
- 2023-01-31 19:00
Page 1 of 4
previousnext